The Role of C-RP / Albumin Ratio in The Diagnosis of Stroke and an Overview of the Factors Affecting Hemispheres

Abstract

Objective: Stroke has an important in emergency room admissions. Co-morbidities can increase the risk of stroke. Infection markers can be used in the diagnosis of stroke. The incidence of stroke originating from the left hemisphere has been reported more than the right. To investigate the accuracy of this situation; We tried to examine our patients who applied to our Emergency Department with stroke symptoms. Materials and Methods: In our study, 1049 patients who presented to our Emergency Department with stroke symptoms and were diagnosed with stroke after neurology consultation were included in our study within 2 years. It was recorded retrospectively whether there was a previous stroke, gender, history of additional disease, infarction region, hemorrhagic or ischemic infarction, whether the C-RP (C-Reactive Protein) / albumin value contributed to this situation was examined. Findings were analyzed with SPSS statistical program, Chi-square and Mann Whitney-U tests. Results: Between 2015 and 2017, 1049 patient findings were evaluated. Hemorrhagic findings were found in 74 (7.05%) of these patients, and ischemic infarction in 975 (92.95%). 875 (83.4%) of these patients had additional disease. Stroke originating from the left hemisphere was detected in 502 (47.9%) patients. C-RP, albumin, C-RP/ albumin values did not differ significantly (p> 0.005) in the group with hemorrhage and infarction. Conclusion: Patients with chronic diseases, especially hypertension, chronic artery disease, diabetes and a history of previous stroke are in the high-risk group in terms of stroke risk. For this, treatment method or risk reduction, measures should be taken before stroke develops.

Keywords

• C-RP/Albumin value
• Diabetes
• Hypertension
• Left Hemisphere Infarction
• Stroke

References

1. 1. Yaltkaya K, Balkan S, Oguz Y. Cerebrovascular Diseases. Textbook of Neurology. Ankara Palme. 1st. Ed. 1996. 179-215.
2. 2. Adams Jr HP, Bendixen BH, Kapelle J, Biller J, Love BB, Gordon DL, et al. The TOAST investigators. Classification of subtypes of acute ischemic stroke. Definition for use in multicenter clinical trial. Stroke.1993;24:35-41
3. 3. Goldstein LB, Adams R, Alberts MJ. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke. Stroke 2006; 37: 1583-1633.
4. 4. Janghorbani M. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses’ Health Study. Diabetes care 30.7.2007; 1730-1735.
5. 5. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA. 2002; 287:2570–2581
6. 6. Lippincott, Williams & Wilkins Primer: The Essentials of High Blood Pressure. 1st. Ed. Baltimore: 1999; 239
7. 7. Prineas J, Marshall J. Hypertension and Stroke. British Medicine Journal, 1966; 1 (5478), 14.
8. 8. Vasan RS, Beiser A, Seshadri S. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002; 287: 1003–1010

9. 9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265: 3255–3264.
10. 10. Sanossian N, Ovbiagele B. Multimodality stroke prevention. Neurologist. 2006;12(1): 14-31.
11. 11. Balkan S, Topçuoğlu M.A. İnme ve Hipertansiyon. Turkiye Klinikleri J Neu. 2004;2(1):41-7.
12. 12. Kocer B. Hypertension and Brain. Turkiye Klinikleri J Cardiol-Special Topics. 2009;2(4):53-8
13. 13. Min J, Farooq M.U, Greenberg E, Aloka F, Bhatt A, Kassab M et al. Cardiac dysfunction after left permanent cerebral focal ischemia: the brain and heart connection. Stroke. 2009; 40(7):2560–3
14. 14. Zia E, Hedblad B, Pessah-Rasmussen H, Berglund G, Janzon L, Engström G. Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage: hypertensive hemorrhage: debated nomenclature is still relevant. Stroke. 2007; 38(10), 2681-2685.
15. 15. Yamori Y, Horie R, Handa H, Sato M, Fukase M. Pathogenic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke. 1976;7(1):46-53
16. 16. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993; 82: 513-20.
17. 17. Chang CY, Chen JY, Ke D, Hu ML. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits. Nutrition. 2005; 21: 987-93.
18. 18. Belayev L, Saul I, Busto R. Albumin treatment reduces neurological deficit and protects blood-brain barrier integrity after acute intracortical hematoma in the rat. Stroke. 2005; 36:326-331.
19. 19. Gotlie AI, Langille BL. The role of rheology in atherosclerotic coronary artery disease. In: Fuster V, Ross R, Topol EJ, ed. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven Publishers. 1996. 595–606.
20. 20. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation: positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis. 1985; 5:293–302.
21. 21. Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med. 1992; 326:221– 225.
22. 22. Snell R.S. Cerebral Dominance. Clinical Neuroanatomy for Medical School Students. Nobel Publisher. Istanbul. 2000. 276–289.
23. 23. Pedersen PM, Jorgensen HS, Nakayama H, Raaschou HO. Hemineglect in acute stroke-incidence and prognostic implications. The Copenhagen stroke study. Am J Phys MedRehabil. 1997;76:122-7